Breaking News Instant updates and real-time market news.

TROX

Tronox

$7.20

-0.1 (-1.37%)

11:30
12/10/18
12/10
11:30
12/10/18
11:30

Aggressive call buy in Tronox and implied volatility reaches 52-week highs

Aggressive call buy in Tronox and implied volatility reaches 52-week highs. The stock off 8c to $7.22 and 1.9K Jan 11s trade 25c when bid-ask was 10 to 25c. Open interest is 703 and the contract is struck 53% above spot. but almost 50% from January 52-week highs of $21.88. 30-day implied volatility up 18% and elevated at 128, as shares now sit at 52-week lows.

TROX Tronox
$7.20

-0.1 (-1.37%)

12/10/18
JPMS
12/10/18
NO CHANGE
Target $17
JPMS
Overweight
Tronox has 60%-65% chance of closing Cristal deal, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas thinks the risk/reward balance for Tronox shares is favorable at current levels. It is reasonable for investors to build positions at current prices following the sharp recent pullback, Zekauskas tells investors in a research note titled "Judgment Day." He believes with a a 60%-65% probability that Tronox can close its deal with Cristal and keeps an Overweight rating on the shares with a $17 price target.
10/02/18
BMOC
10/02/18
NO CHANGE
Target $13
BMOC
Outperform
Tronox price target lowered to $13 from $28 at BMO Capital
BMO Capital analyst John McNulty lowered his price target on Tronox (TROX) to $13 to adjust for the expiration of the exclusivity window to divest its Ashtabula assets to Venator Materials (VNTR). The analyst expects the company to open up conversations on Ashtabula spinoff, which is required for the Cristal deal to be approved, with a wider range of potential bidders but likely at lower prices. Longer term, McNulty keeps his Outperform rating on Venator, noting that he expects the titanium dioxide "speed bump" to be short lived while the company also works to close on Cristal.
09/28/18
JPMS
09/28/18
NO CHANGE
Target $17
JPMS
Overweight
Tronox is 'down, but not out,' says JPMorgan
In a research note titled "Down, but Not Out," JPMorgan analyst Jeffrey Zekauskas keeps an Overweight rating on shares of Tronox. He also lowered his price target for the stock to $17 from $22. The analyst believes Tronox should close its merger with Cristal by the end of 2018 and that the deal "would be quite beneficial to the value" of the company. He expects the company to divest the 245kt of titanium dioxide production in Ashtabula, Ohio owned by Cristal to another party. Tronox offers a 17% free cash flow yield for 2019 and something less than 30% free cash flow yield for 2020, Zekauskas tells investors in a research note.
07/31/18
RHCO
07/31/18
INITIATION
Target $24
RHCO
Buy
Tronox initiated with a Buy at SunTrust
SunTrust analyst James Sheehan initiated Tronox with a Buy rating and a price target of $24 as part of his broader research note suggesting that the titanium dioxide, or TiO2, upcycle is nearing a peak. Despite the pricing pressure, the analyst expects Tronox to become one of the two largest global TiO2 producers pending a merger with Saudi-owned Cristal and contingent on U.S. regulator approval. Sheehan also sees the company benefiting from "tightening mineral sands supply/demand and stable profitability in TiO2 over the next 12 months", allowing the company to generate $100M of synergies in the first year of the acquisition.

TODAY'S FREE FLY STORIES

TRQ

Turquoise Hill

$0.45

(0.00%)

05:20
11/19/19
11/19
05:20
11/19/19
05:20
Hot Stocks
Turquoise Hill notes Administrative Court proceedings in Mongolia »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRARY

Credit Agricole

$0.00

(0.00%)

05:18
11/19/19
11/19
05:18
11/19/19
05:18
Upgrade
Credit Agricole rating change  »

Credit Agricole upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$369.50

-2.05 (-0.55%)

05:16
11/19/19
11/19
05:16
11/19/19
05:16
Hot Stocks
Boeing: Air Astana intends to buy 30 737 MAX airplanes »

Air Astana intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.63

-1.36 (-5.67%)

05:15
11/19/19
11/19
05:15
11/19/19
05:15
Recommendations
Jefferies still expects Amarin shares to rise toward $30 »

Following the data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BB

BlackBerry

$5.28

-0.195 (-3.56%)

05:15
11/19/19
11/19
05:15
11/19/19
05:15
Hot Stocks
BlackBerry QNX technology to power Arrival intelligent, autonomous-ready EVs »

BlackBerry and electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 06

    Jan

ATRS

Antares Pharma

$4.28

0.12 (2.88%)

05:10
11/19/19
11/19
05:10
11/19/19
05:10
Hot Stocks
Antares Pharma enters into global development agreement with Idorsia »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XONE

ExOne

$7.00

-0.05 (-0.71%)

, ANSS

Ansys

$238.67

3.63 (1.54%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Hot Stocks
ExOne announces collaboration with Ansys »

ExOne (XONE) and ANSYS…

XONE

ExOne

$7.00

-0.05 (-0.71%)

ANSS

Ansys

$238.67

3.63 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

, BBIO

BridgeBio

$29.06

0.8 (2.83%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Recommendations
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray »

Piper Jaffray analyst…

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

BBIO

BridgeBio

$29.06

0.8 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

05:01
11/19/19
11/19
05:01
11/19/19
05:01
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.54

0.18 (0.34%)

04:59
11/19/19
11/19
04:59
11/19/19
04:59
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CSL

Carlisle

$161.08

0.12 (0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Carlisle management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KRP

Kimbell Royalty Partners

$14.18

0.19 (1.36%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Kimbell Royalty Partners management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SU

Suncor

$31.84

-0.64 (-1.97%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Suncor management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ASML

ASML

$273.38

-1.35 (-0.49%)

, ERIC

Ericsson

$9.10

-0.04 (-0.44%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
JPMorgan to hold a conference »

Global TMT…

ASML

ASML

$273.38

-1.35 (-0.49%)

ERIC

Ericsson

$9.10

-0.04 (-0.44%)

IMAX

Imax

$20.88

-0.19 (-0.90%)

SIMO

Silicon Motion

$42.65

0.03 (0.07%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 06

    Jan

ACCO

Acco Brands

$9.42

0.035 (0.37%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Acco Brands management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stephens business services analyst to hold a group luncheon »

Group Luncheon Meeting to…

CSGS

CSG

$57.54

0.54 (0.95%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
CSG management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

ADM

Archer Daniels

$42.84

-0.03 (-0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Archer Daniels management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AHT

Ashford Hospitality

$2.70

-0.005 (-0.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMSF

Amerisafe

$65.49

-0.15 (-0.23%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Amerisafe management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

ESVIF

Ensign Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ensign Energy management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FC

Franklin Covey

$37.20

-0.3 (-0.80%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Franklin Covey management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PSNL

Personalis

$8.89

-0.85 (-8.73%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Personalis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

SLNG

Stabilis Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stabilis Energy management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.